FDA Clears Rapid PCR System for Rapid Respiratory Virus Testing
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
Read MorePosted by CLP Edit Staff | Jun 16, 2026 | Flu & Respiratory Infections, Molecular Diagnostics |
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Emerging Andes virus cases—capable of person-to-person transmission—are prompting US clinical labs to reassess hantavirus protocols and consider travel and epidemiologic exposures beyond rodent contact.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Company News, Infectious Diseases, Molecular Diagnostics |
Co-Diagnostics has completed its assay development strategy for Bundibugyo virus, following the WHO’s emergency declaration and CDC’s updated traveler screening measures amid ongoing Ebola outbreaks in the DRC and Uganda.
Read MorePosted by CLP Edit Staff | May 12, 2026 | Infectious Diseases, Microbiology, Molecular Diagnostics |
Laboratories are leveraging established diagnostic and surveillance tools to track the Andes hantavirus outbreak linked to a cruise ship, with experts noting no evidence of widespread community transmission or efficient airborne spread.
Read MorePosted by CLP Edit Staff | Apr 30, 2026 | Infectious Diseases, Molecular Diagnostic Analyzers, Molecular Diagnostics |
A study finds the battery-powered MiniDock MTB delivers lab-accurate tuberculosis results from tongue swabs in under 30 minutes.
Read More